2072145-54-9
Chemical Structure
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine
- CAS. Nr.: 2072145-54-9
- Formula:C32H27NO9
- Molecular Weight:569.56
IUPAC Name: (2R,3R,4R,5R)-5-((benzoyloxy)methyl)-2-(4-hydroxy-2-oxopyridin-1(2H)-yl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate
InChIKey: WYSNHADTYOOXCV-VHPOQJMKSA-N
SMILES: C[C@@]1(OC(C2=CC=CC=C2)=O)[C@H](OC(C3=CC=CC=C3)=O)[C@@H](COC(C4=CC=CC=C4)=O)O[C@H]1N5C(C=C(O)C=C5)=O
Biological Activity: 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine | 2’,3’,5’-Tri-O-benzoyl-2’-β-C-methyl-3-deazauridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
